Skip to main content

Advertisement

Log in

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

We evaluated, in a nonrandomised, institutional, prospective study, the efficacy of photodynamic therapy (PDT) with verteporfin in age-related macular degeneration (AMD) eyes with polypoidal choroidal vasculopathy (PCV) and subfoveal exudation.

Methods

A prospective clinical and angiographic study was done in 40 consecutive eyes with PCV treated with PDT using masked best-corrected visual acuity (VA) and fluorescein and indocyanine green angiographic features at baseline and over 2 years.

Results

Twenty-one eyes completed 1-year follow-up and showed, after a mean 2.9 PDT sessions, VA improvement in 12 eyes, no change in five eyes, and VA decrease in four eyes. Leakage was absent at the retinal and choroidal level in 14 eyes at 1 year. Recurrence occurred in one eye during the first year. Six eyes completed 2 years of follow-up and showed, after a mean 4 PDT sessions, VA improvement in five eyes and VA decrease in one eye. Leakage was absent at the retinal and choroidal level in five eyes. Recurrence occurred in four of these six eyes during the second year of follow-up. No serious adverse events were observed during the 2 years of follow-up.

Conclusions

PDT with verteporfin was shown to be safe and effective for treating AMD eyes with PCV with subfoveal involvement. VA improvement and absence of leakage were achieved, respectively, in 57.1% and 66.6% of the eyes at 1 year. Recurrences were more frequent during the second year of follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chan WM, Lam DSC, Lai TYY, Liu DTL, Li KKW, Yao Y, Wong TH (2004) Photodynamic therapy with verteprofin for symptomatic polypoidal choroidal vasculopathy. Ophthalmology 111:1576–1584

    Article  PubMed  Google Scholar 

  2. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25–37

    Article  PubMed  Google Scholar 

  3. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Hope-Ross M, Orlock DR (1994) Digital indocyanine-green video angiography of occult choroidal neovascularisation. Ophthalmology 101:1727–1737

    PubMed  CAS  Google Scholar 

  4. Kwok AK, Lay TY, Chan CW, et al. (2002) Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 86:892–897

    Article  PubMed  CAS  Google Scholar 

  5. Lafaut BA, Leys AM, Snyers B, et al. (2000) Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Cin Exp Ophthalmol 238:752–759

    Article  CAS  Google Scholar 

  6. Quaranta M, Maget-Faysse M, Coscas G (2002) Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol 134:277–280

    Article  PubMed  Google Scholar 

  7. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal horoidal vasculopathy. Retina 15:100–110

    Article  PubMed  CAS  Google Scholar 

  8. Stern RM, Zakov N, Zegarra H, Gutman FA (1985) Multiple recurrent serosanguinous retinal pigment epithelial detachments in black women. Am J Ophthalmol 100:560–569

    PubMed  CAS  Google Scholar 

  9. Bresller NM, Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials–TAP report 2. Arch Ophthalmol 119:198–207

    PubMed  Google Scholar 

  10. Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–648

    Article  PubMed  Google Scholar 

  11. Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularisation in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol 131:541–560

    Article  PubMed  Google Scholar 

  12. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115:478–485

    PubMed  CAS  Google Scholar 

  13. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rufino M. Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, R.M., Figueira, J., Cachulo, M.L. et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefe's Arch Clin Exp Ophthalmo 243, 973–979 (2005). https://doi.org/10.1007/s00417-005-1139-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-005-1139-4

Keywords

Navigation